
Apollo Hospitals reported a 34% rise in net profit to Rs 581 crore for the June quarter, beating street estimates. Revenue grew 21% to Rs 7,043 crore, driven by high speciality volumes…
Apollo Hospitals reported a 34% rise in net profit to Rs 581 crore for the June quarter, beating street estimates. Revenue grew 21% to Rs 7,043 crore, driven by high speciality volumes in cardiology, oncology and transplants. The chain is adding 5,800 beds over five years, with new hospitals in Sarjapur, Indore and Dwarka.

Cancer-care chain HCG nearly tripled its profit to Rs 16.5 crore on revenue of Rs 707 crore, up 14%. It added 121 beds, including a new hospital in North Bengaluru that recorded 550 registrations in its first weeks. HCG plans to add 1,000 beds by FY30, with most expansion at existing centres.
These results fuel the narrative that Indian healthcare is a guaranteed growth story. But the picture is patchy. Apollo’s margin is only 15.5%, and HCG’s profit base remains tiny despite the surge. Both chains are betting big on bed expansion, but filling new capacity is not automatic. Watch whether HCG’s new North Bengaluru hospital maintains its early traction and if Apollo’s Gurugram facility opens on schedule in Q3.
Sources (2): timesofindia.indiatimes.com, livemint.com
This story was synthesised by AI from the 2 sources linked above.
Updated: this story now draws on 2 sources.